{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:09:03Z","timestamp":1761764943845},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1007\/s11934-001-0078-9","type":"journal-article","created":{"date-parts":[[2007,6,11]],"date-time":"2007-06-11T09:34:40Z","timestamp":1181554480000},"page":"195-198","source":"Crossref","is-referenced-by-count":21,"title":["High grade prostatic intraepithelial neoplasia is a disease"],"prefix":"10.1007","volume":"2","author":[{"given":"Mitchell S.","family":"Steiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"78_CR1","first-page":"74","volume-title":"Prostate: Basic and Clinical Aspects","author":"SM Ho","year":"1997","unstructured":"Ho SM, Lee KF, Lane K: Neoplastic transformation of the prostate. In Prostate: Basic and Clinical Aspects. Edited by Naz RK. Toledo, OH: Medical College of Ohio; 1997:74\u2013114."},{"key":"78_CR2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0046-8177(92)90104-B","volume":"23","author":"MK Brawer","year":"1992","unstructured":"Brawer MK: Prostatic intraepithelial neoplasia: a premalignant lesion. Hum Pathol 1992, 23:242.","journal-title":"Hum Pathol"},{"key":"78_CR3","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/1097-0142(19950401)75:7+<1823::AID-CNCR2820751612>3.0.CO;2-7","volume":"75","author":"DG Bostwick","year":"1995","unstructured":"Bostwick DG: High-grade prostatic intra-epithelial neoplasia: the most likely precursor of prostate cancer. Cancer 1995, 75:1823\u20131836.","journal-title":"Cancer"},{"key":"78_CR4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ajcp\/101.1.48","volume":"101","author":"EC Jones","year":"1994","unstructured":"Jones EC, Young RH: The differential diagnosis of prostatic carcinoma. Its distinction from premalignant and pseudo-carcinomatous lesions of the prostate gland. Am J Clin Pathol 1994, 101:48.","journal-title":"Am J Clin Pathol"},{"key":"78_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00193163","volume":"426","author":"BG Helpap","year":"1995","unstructured":"Helpap BG, Bostwick DG, Montironi R: The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update. Virchows Arch 1995, 426:425\u2013434.","journal-title":"Virchows Arch"},{"key":"78_CR6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<330::AID-CNCR22>3.0.CO;2-W","volume":"78","author":"DG Bostwick","year":"1996","unstructured":"Bostwick DG: Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer 1996, 78:330\u2013336.","journal-title":"Cancer"},{"key":"78_CR7","first-page":"283","volume":"19","author":"DG Bostwick","year":"1994","unstructured":"Bostwick DG, Burke HB, Wheeler TM: The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials. J Cell Biochem Suppl 1994, 19:283\u2013289.","journal-title":"J Cell Biochem Suppl"},{"key":"78_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1097-0045(199608)29:2<117::AID-PROS7>3.0.CO;2-C","volume":"29","author":"DG Bostwick","year":"1996","unstructured":"Bostwick DG: Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996, 29:117\u2013134.","journal-title":"Prostate"},{"key":"78_CR9","first-page":"16","volume":"34","author":"DG Bostwick","year":"1989","unstructured":"Bostwick DG: Prostatic intraepithelial neoplasia (PIN). Urology 1989, 34:16\u201322.","journal-title":"Urology"},{"key":"78_CR10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jcb.240501205","volume":"16H","author":"DG Bostwick","year":"1992","unstructured":"Bostwick DG: Prostatic intraepithelial neoplasia (PIN): current concepts. J Cell Biochem 1992, 16H:10\u201319.","journal-title":"J Cell Biochem"},{"key":"78_CR11","doi-asserted-by":"crossref","unstructured":"Stanford JL: Epidemiology of prostate cancer. Prostate Cancer. WHO 2nd International Consultation on Prostate Cancer 1999, 23\u201355.","DOI":"10.1038\/sj\/pcan\/4500298"},{"key":"78_CR12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0090-4295(89)90369-5","volume":"34","author":"JR Drago","year":"1989","unstructured":"Drago JR, Mostofi FK, Lee F: Introductory remarks and workshop summary. Urology 1989, 34(suppl):2\u20133.","journal-title":"Urology"},{"key":"78_CR13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1159\/000019886","volume":"35","author":"F Algaba","year":"1999","unstructured":"Algaba F: Evolution of isolated high-grade prostate intraepithelial neoplasia in a Mediterranean patient population. Eur Urol 1999, 35:496\u2013497.","journal-title":"Eur Urol"},{"key":"78_CR14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<362::AID-CNCR28>3.0.CO;2-T","volume":"78","author":"R Montironi","year":"1996","unstructured":"Montironi R, Bostwick DG, Bonkhoff H: Origins of prostate cancer. Cancer 1996, 78:362\u2013365.","journal-title":"Cancer"},{"key":"78_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11934-000-0037-x","volume":"1","author":"DG Bostwick","year":"2000","unstructured":"Bostwick DG: Prostatic intraepithelial neoplasia. Current Urology Reports 2000, 1:65\u201370. A practical guide for the current understanding of high grade PIN and its impact on clinical urology.","journal-title":"Current Urology Reports"},{"key":"78_CR16","first-page":"187","volume":"17","author":"DG Bostwick","year":"1999","unstructured":"Bostwick DG: Prostatic Intraepithelial neoplasia is a risk factor for cancer. Urol Oncol 1999, 17:187\u2013198. This study defines the significance of high grade PIN to the clinician.","journal-title":"Urol Oncol"},{"key":"78_CR17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-5347(17)35487-3","volume":"150","author":"WA Sakr","year":"1993","unstructured":"Sakr WA, Haas GP, Cassin BF, et al.: The frequency of carcinoma and epithelial neoplasia of the prostate in young male patients. J Urol 1993, 150:379\u2013385.","journal-title":"J Urol"},{"key":"78_CR18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0344-0338(11)80965-9","volume":"191","author":"WA Sakr","year":"1995","unstructured":"Sakr WA, Grignon DJ, Haas GP, et al.: Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol Res Pract 1995, 191:838\u2013841.","journal-title":"Pathol Res Pract"},{"key":"78_CR19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000019882","volume":"35","author":"WA Sakr","year":"1999","unstructured":"Sakr WA: Prostatic intraepithelial neoplasia: a marker for high-risk groups and a potential target for chemoprevention. Eur Urol 1999, 35:474\u2013478.","journal-title":"Eur Urol"},{"key":"78_CR20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0046-8177(86)80156-3","volume":"17","author":"JE McNeal","year":"1986","unstructured":"McNeal JE, Bostwick DG: Intraductal dysplasia: a pre-malignant lesion of the prostate. Hum Pathol 1986, 17:64\u201371.","journal-title":"Hum Pathol"},{"key":"78_CR21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0090-4295(00)00447-7","volume":"55","author":"GJ O'dowd","year":"2000","unstructured":"O'dowd GJ, Miller MC, Orozco R, Veltri RW: Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology 2000, 55:553\u2013559.","journal-title":"Urology"},{"key":"78_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.pcan.4500277","volume":"2","author":"WA Sakr","year":"1999","unstructured":"Sakr WA, Brawer MK, Moul JW: Pathology and bio markers of prostate cancer. Prostate Cancer and Prostatic Diseases 1999, 2:7\u201314.","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"78_CR23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/(SICI)1097-0215(19971210)73:6<808::AID-IJC6>3.0.CO;2-6","volume":"73","author":"MQ Fujita","year":"1997","unstructured":"Fujita MQ, Shin M, Yasunaga Y, et al.: Incidence of prostatic intra-epithelial neoplasia in Osaka, Japan. Int J Cancer 1997, 73:808\u2013811.","journal-title":"Int J Cancer"},{"key":"78_CR24","first-page":"127","volume":"9","author":"GJ Kelloff","year":"2000","unstructured":"Kelloff GJ, Sigman CC, Johnson KM, et al.: Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer. Cancer Epidemiol Biomarkers Prev 2000, 9:127\u2013137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"78_CR25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.pcan.4500274","volume":"2","author":"GJ Kelloff","year":"1999","unstructured":"Kelloff GJ, Lieberman R, Brawer MK: Strategies for chemo-prevention of prostate cancer. Prostate Cancer and Prostatic Diseases 1999, 2:27\u201333. The NCI's position on the current strategies used for the development of prostate cancer chemoprevention clinical trials.","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"78_CR26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000019906","volume":"35","author":"GJ Kelloff","year":"1999","unstructured":"Kelloff GJ, Lieberman R, Steele VE, et al.: Chemoprevention of prostate cancer: concepts and strategies. Eur Urol 1999, 35:342\u2013350. A comprehensive review of clinical trials being conducted in prostate chemoprevention by the NCI, as well as a rationale for certain patient cohorts.","journal-title":"Eur Urol"},{"key":"78_CR27","first-page":"4743","volume":"59","author":"MB Sporn","year":"1999","unstructured":"Sporn MB: Prevention of cancer in the next millennium: report of the chemoprevention working group to the American association for cancer research. Cancer Res 1999, 59:4743\u20134758. An outstanding and complete report discussing the great need for and the challenges facing cancer prevention from the American Association of Cancer Research Committee on Chemoprevention.","journal-title":"Cancer Res"},{"key":"78_CR28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/clinchem\/44.2.420","volume":"44","author":"R Lieberman","year":"1998","unstructured":"Lieberman R, Lieberman R, Steele VE, et al.: Development of new cancer chemoprevention agents: role of pharma-cokinetic\/ pharmacodynamic and intermediate endpoint biomarker monitoring. Clin Chem 1998, 44:420\u2013427.","journal-title":"Clin Chem"},{"key":"78_CR29","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0022-5347(05)68172-4","volume":"162","author":"CG Ramos","year":"1999","unstructured":"Ramos CG, Carvahal GF, Mager DE: The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels. J Urol 1999, 162:1587\u20131590.","journal-title":"J Urol"},{"key":"78_CR30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1464-410x.1999.00213.x","volume":"84","author":"J Morote","year":"1999","unstructured":"Morote J, Carvahal GF, Mager DE, et al.: Influence of high-grade prostatic intra-epithelial neoplasia on total and percentage free serum prostatic specific antigen. BJU Int 1999, 84:657\u2013660.","journal-title":"BJU Int"},{"key":"78_CR31","doi-asserted-by":"crossref","unstructured":"Zlotta AR, Schulman CC: Chemoprevention in prostate cancer. Suppl Rev Urol 1999, 35\u201340.","DOI":"10.1159\/isbn.978-3-318-00427-4"},{"key":"78_CR32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-5347(01)65881-6","volume":"156","author":"D Shepherd","year":"1996","unstructured":"Shepherd D, Keetch DW, Humphrey PA, et al.: Repeat biopsy strategy in men with isolated prostatic intraepithelial neo-plasia on prostate needle biopsy. J Urol 1996, 156:460\u2013463.","journal-title":"J Urol"},{"key":"78_CR33","unstructured":"Kronz JD, Shaikh AA, Epstein JI: High grade prostatic intra-epithelial neoplasia with adjacent small atypical glands on biopsy. Paper presented at Annual Meeting of the American Urological Association. May 2000. Atlanta, GA, Abstract #1236."},{"key":"78_CR34","first-page":"279","volume":"163","author":"FF Pasqualotto","year":"2000","unstructured":"Pasqualotto FF, Zippe CD, Sekhon V: Repeat sextant TRUS-guided needle biopsy for prostatic intraepithelial neoplasia (PIN) does not require transition zone sampling. J Urol 2000, 163:279.","journal-title":"J Urol"},{"key":"78_CR35","first-page":"279","volume":"163","author":"B Leibovich","year":"2000","unstructured":"Leibovich B, Kuntzman RS, Wilson TM: Sextant biopsy of the prostate is inadequate for cancer detection in men with high grade prostatic intraepithelial neoplasia. J Urol 2000, 163:279.","journal-title":"J Urol"},{"key":"78_CR36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000480850","volume":"32","author":"M Perachino","year":"1997","unstructured":"Perachino M, di Ciolo L, Barbetti V, et al.: Results of rebiopsy for suspected prostate cancer in symptomatic men with elevated PSA levels. Eur Urol 1997, 32:155\u2013159.","journal-title":"Eur Urol"},{"key":"78_CR37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1159\/000019888","volume":"35","author":"D Newling","year":"1999","unstructured":"Newling D: PIN I-III: when should we interfere? Eur Urol 1999, 35:504\u2013507.","journal-title":"Eur Urol"},{"key":"78_CR38","first-page":"40","volume":"1","author":"JR Marshall","year":"2000","unstructured":"Marshall JR: Chemoprevention of prostate cancer in a high-risk population. O-N-E 2000, 1:40\u201344.","journal-title":"O-N-E"},{"key":"78_CR39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1159\/000019885","volume":"35","author":"DG Bostwick","year":"1999","unstructured":"Bostwick DG, Neumann R, Qian J, Cheng L: Reversibility of prostatic intraepithelial neoplasia: implications for chemoprevention. Eur Urol 1999, 35:492\u2013495.","journal-title":"Eur Urol"},{"key":"78_CR40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00005392-199909010-00035","volume":"162","author":"KC Balaji","year":"1999","unstructured":"Balaji KC, et al.: Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance. J Urol 1999, 162:753\u2013757.","journal-title":"J Urol"},{"key":"78_CR41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0090-4295(94)80015-4","volume":"44","author":"J Ferguson","year":"1994","unstructured":"Ferguson J, Zincke H, Ellison E, et al.: Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage t3 carcinoma treated by radical prostatectomy. Adult Urol 1994, 44:91\u201395.","journal-title":"Adult Urol"},{"key":"78_CR42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00000478-199601000-00010","volume":"20","author":"L Vailancourt","year":"1996","unstructured":"Vailancourt L, Ttu B, Fradet Y, et al.: Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. Am J Surg Pathol 1996, 20:86\u201393.","journal-title":"Am J Surg Pathol"},{"key":"78_CR43","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000019889","volume":"35","author":"TH Kwast van der","year":"1999","unstructured":"van der Kwast TH, Labrie F, Tetu B: Prostatic intraepithelial neoplasia and endocrine manipulation. Eur Urol 1999, 35:508\u2013510.","journal-title":"Eur Urol"},{"key":"78_CR44","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0046-8177(99)90174-0","volume":"30","author":"TH Kwast van der","year":"1999","unstructured":"van der Kwast TH, Labrie F, Tetu B: Prostatic intraepithelial neoplasia and endocrine manipulation. Hum Pathol 1999, 30:1503\u20131507.","journal-title":"Hum Pathol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-001-0078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-001-0078-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-001-0078-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T01:11:12Z","timestamp":1587604272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-001-0078-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s11934-001-0078-9","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}